AI assistant
Sending…
N4 PHARMA PLC — Major Shareholding Notification 2016
Apr 15, 2016
7804_mrq_2016-04-15_bd525e32-59d1-4ee0-bf1d-ad00db710230.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4069V
Verona Pharma PLC
15 April 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Verona Pharma plc | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | √ | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Aviva plc & its subsidiaries | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | Registered Holder: BNY Norwich Union Nominees Limited 4,565,531* Chase (GA Group) Nominees Limited 139,363,819* Available on request 124,125* *denotes direct interest Chase (GA Group) Nominees Limited 15,153,796 Chase Nominees Limited 3,872,597 Vidacos Nominees Limited 18,701,411 |
||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
14 April 2016 | ||||
| 6. Date on which issuer notified: | 15 April 2016 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
18% to 17% Change at Combined Interest Level | ||||
| 8. Notified details: | |||||||||||
| A: Voting rights attached to shares viii, ix | |||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | |||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||
| Ordinary Shares GB00B06GSH43 |
182,250,000 | 182,250,000 | 181,781,279 | 144,053,475 | 37,727,804 | 14.26% | 3.73% | ||||
| B: Qualifying Financial Instruments | |||||||||||
| Resulting situation after the triggering transaction | |||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
| Resulting situation after the triggering transaction | ||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |
| Nominal | Delta | |||||
| Total (A+B+C) | |
| Number of voting rights | Percentage of voting rights |
| 181,781,279 | 17.99% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
|
| The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) · Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) · Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) · Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) · Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) |
|
| Proxy Voting: | |
| 10. Name of the proxy holder: | See Section 4 |
| 11. Number of voting rights proxy holder will cease to hold: |
|
| 12. Date on which proxy holder will cease to hold voting rights: |
| 13. Additional information: | Figures are based on a total number of voting rights of 1,009,923,481, as per the Company's Result of General Meeting Announcement of 24 March 2014. |
| 14. Contact name: | Neil Whittaker, Aviva plc |
| 15. Contact telephone number: | 01603 684420 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGUCUCUPQGAA
More from N4 PHARMA PLC
Regulatory Filings
2026
Apr 20
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 17
Regulatory Filings
2026
Feb 27
Board/Management Information
2026
Feb 24
Regulatory Filings
2025
Dec 18
Interim / Quarterly Report
2025
Sep 25
Regulatory Filings
2025
Sep 23
Regulatory Filings
2025
Sep 22
Report Publication Announcement
2025
Sep 19
Regulatory Filings
2025
Sep 11